Gleneagles Hospital Kuala Lumpur (GKL) is one of the leading private hospitals in
Malaysia's metropolitan capital of Kuala Lumpur and is a 376-bedded hospital that
offers patients a comfortable ambience with outstanding medical care. A part of IHH
Healthcare, GKL has grown into a highly respected and reputable healthcare service
provider in Malaysia and the Southeast Asian region; providing excellent
professional healthcare services to local and international patients.
Our commitment to excellence is evident through continuous enhancements to our
hospital facilities and investments in cutting-edge technology, setting us apart in
the industry. GKL is committed to the provision of safe and quality healthcare and
is proud to have a team of highly qualified and experienced medical professionals,
consultants, and nurses who go the extra mile to ensure an exceptional patient
experience.
GKL is also home to some of the most advanced medical technologies and procedures
available such as:
Gamma Knife Radiosurgery – A breakthrough in the medical
field; as way to treat not only brain tumours but also vascular malformations and
functional disorders through a minimally invasive way. The treatment procedure is
simple, painless, straightforward and provides better outcomes as compared to
traditional brain surgery.
Da Vinci Si Surgical System – A surgical platform designed to
enable complex surgery by using a minimally invasive approach. Powered by robotic
technology, Da Vinci Si surgical system allows surgeons to perform intricate
surgeries with utmost meticulousness.
Download our E-Corporate Brochure here: https://online.flippingbook.com/view/176133662/
ABOUT IHH HEALTHCARE
IHH is a leading multinational healthcare provider shaping the future of care. Driven by our aspiration to Care. For Good., we unite medical excellence and innovation, pushing boundaries through our trusted brands such as Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway and Prince Court.
Across 10 countries, including Malaysia, Singapore, Türkiye, India and Greater China, our 76,000-strong team delivers world-class excellence every day, within and beyond our 190 healthcare facilities, including 89 hospitals.
Within Malaysia, IHH operates 18 hospitals with approximately 3,600 beds under trusted brands including Gleneagles, Island Hospital, Pantai, Prince Court and Timberland Medical Centre. Supported by ancillary services such as Premier Integrated Labs, Premier Integrated Rehab and primary care clinics under Twin Towers Medical Centre, our more than 15,000 staff and 2,000 consultants deliver comprehensive care across the healthcare continuum, from primary and ambulatory to tertiary and quaternary services, complemented by diagnostics and rehabilitation.
In partnership with our stakeholders, IHH is advancing value-based care, building a sustainable healthcare ecosystem and creating meaningful impact, as we work towards our vision to become the world’s most trusted healthcare services network.
www.ihhhealthcare.com
Our CEO
Linda Leong Miao Ling
Chief Executive Officer,
Gleneagles Hospital Kuala Lumpur
Linda Leong Miao Ling is the Chief Executive Officer of Gleneagles Hospital Kuala Lumpur.
Since joining IHH Healthcare Malaysia in 2014, she has held progressively broader leadership roles across Medical Affairs, Operations and Hospital Management. She previously served as Chief Operating Officer at Gleneagles Hospital Kuala Lumpur and Pantai Hospital Klang, and as Chief Executive Officer of Pantai Hospital Cheras, before taking on a Chief Executive Officer role outside of the IHH network. Her experience reflects both continuity within IHH Healthcare Malaysia and broader executive exposure beyond the network.
During her tenure as Chief Operating Officer at Gleneagles Hospital Kuala Lumpur, Linda led initiatives to modernise infrastructure and strengthen clinical capabilities. She oversaw the implementation of a new hospital information system and advanced service capabilities across radiology, oncology, robotic surgery and neurosurgery, reinforcing the hospital’s capacity in complex and tertiary care. She also played a key role in establishing the one-stop Heart Specialist Clinic and Cardiac Diagnostic Unit, and in expanding interventional cardiology services with the addition of a cardiac catheterisation laboratory.
Since 1996, GKL has provided high-quality healthcare, complemented by friendly and
professional staff. As we strive to deliver excellent healthcare and patient
services to our community, a good measure of our performance is recognised in the
form of awards and accreditation by third-party institutions.
GKL was one of the first private hospitals in Malaysia to be accredited by the
US-based Joint Commission International (JCI); while locally we are accredited by
the Malaysian Society for Quality in Health (MSQH).
JCI since 2010 (5 cycles renewal)

Joint Commission International (JCI)
MSQH since 2013 (6 cycles renewal)

Malaysian Society for Quality in Health(MSQH)
At Gleneagles Hospital Kuala Lumpur, patient safety and quality of care are our highest priorities. If you have concerns that require external review, you may contact the Joint Commission International (JCI) directly at https://www.jointcommission.org/en/contact-us
In addition, other recent notable awards that attest to the quality of care at GKL
include:
Newsweek
Top 250 World’s Best Hospital 2025
Top 3 World’s Best Hospital 2025 - Malaysia
Reader’s Digest Trusted Brand 2025
Newsweek
Top 250 World’s Best Hospital 2024
#1 World’s Best
Hospital 2024 - Malaysia
GlobalHealth Asia-Pacific Awards 2024
Hospital of the Year in Malaysia by GlobalHealth Asia-Pacific 2024
Malaysia Technology
Excellence Awards 2024
Robotics - Healthcare
Reader’s Digest Trusted Brand 2024
Frost & Sullivan Awards
2023
Customer Value Leadership Award 2023
Global Health Asia Pacific Awards
2023
Hospital of the Year in Malaysia by GlobalHealth Asia-Pacific 2023
Customer Care Service Provider of the year in Asia-Pacific by
GlobalHealth Asia-Pacific 2023
Endocrinology Service Provider of the year in Asia-Pacific by
GlobalHealth Asia-Pacific 2023
Gastroenterology Service Provider of the year in Asia-Pacific by
GlobalHealth Asia-Pacific 2023
ICU Service Provider of the year in Asia-Pacific by GlobalHealth
Asia-Pacific 2023
Neurology Service Provider of the year in Asia-Pacific by GlobalHealth
Asia-Pacific 2023
Prostate Care Service Provider of the year in Asia-Pacific by
GlobalHealth Asia-Pacific 2023
Reader’s Digest Trusted Brand 2023
Malaysia Health & Wellness Awards 2022
Corporate Social Responsibility
Malaysia Technology Excellence Awards 2023
Medical Technology (Healthcare)
Healthcare Asia Awards 2023
Service Innovation of the Year – Malaysia
Malaysia Health & Wellness Awards
2022
Corporate Social Responsibility
IHH Summit 2022
IHH GCEO Clinical Award for Clinical Effective 2022
Global Health Asia Pacific Awards 2022
Hospital Of The Year In Malaysia 2022
Value Based Hospital Of The Year In Asia-Pacific 2022
Endocrinology Service Provider OF The Year In Asia-Pacific 2022
Bariatric Service Provider Of The Year In Asia-Pacific 2022
Global Health Asia Pacific Awards 2021
Value Based Hospital Of The Year in The Asia-Pacific 2021
Diabetes Service Provider Of The Year In Asia-Pacific 2021
Endocrinology Service Provider Of The Year In Asia-Pacific 2021
Global Health Asia Pacific Awards 2020
Bariatric Service Provider Of The Year In Asia-Pacific 2020
At Gleneagles Hospital Kuala Lumpur, we are committed to conducting business with the
utmost integrity, with a zero-tolerance policy for bribery and corruption.
Our anti-bribery and corruption guidelines (available here) outline the principles that guide our actions
and decisions.
These guidelines serve as a resource for our employees, partners, suppliers, and
stakeholders, providing clear guidance on identifying, preventing, and reporting
instances of bribery and corruption. By adhering to these principles, we contribute
to fostering a culture of trust and integrity within our organisation and beyond.
We encourage all individuals associated with Gleneagles Hospital Kuala Lumpur to
familiarise themselves with these guidelines to promote a culture of ethical conduct
and compliance.